Advancements in Prenatal Genetic Screening and Testing: Emerging Technologies and Evolving Applications

Area of Science:

• Genomics
• Reproductive Medicine
• Genetic Diagnostics

Background:

• Prenatal genetic testing has undergone significant transformation due to technological advancements.
• Current methods offer improved accuracy, comprehensiveness, and noninvasive options for reproductive care.

Purpose of the Study:

• To provide an in-depth review of current and emerging prenatal genomic testing methodologies.
• To assess the clinical utility and limitations of these advanced diagnostic tools.

Main Methods:

• Review of expanded carrier screening (ECS), cell-free DNA (cfDNA) testing, chromosomal microarray analysis (CMA), and sequencing-based diagnostics.
• Highlighting the impact of next-generation sequencing (NGS) on carrier screening and fetal genome analysis.
• Discussion of emerging technologies like optical genome mapping and RNA sequencing.

Main Results:

• Next-generation sequencing (NGS) has revolutionized carrier screening and fetal genome analysis for a broad spectrum of genetic conditions.
• Cell-free DNA (cfDNA) testing now extends beyond aneuploidies to include copy number variants (CNVs) and single-gene disorders.
• Genome sequencing demonstrates superior performance over CMA and exome sequencing for detecting sequence and structural variants.

Conclusions:

• Technological advancements, particularly NGS and cfDNA, have significantly enhanced prenatal genetic testing capabilities.
• Emerging tools promise to further increase diagnostic yield and improve variant interpretation in prenatal genomics.
• The review summarizes key advancements, clinical utility, limitations, and future directions in the field.